Coport L Tablet 25 mg + 5 mg combines Empagliflozin and Linagliptin for the management of type 2 diabetes mellitus. Empagliflozin, an SGLT2 inhibitor, lowers blood glucose by promoting urinary glucose excretion, while Linagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucagon levels. This higher-strength formulation is ideal for patients who need intensified glycemic control or have not achieved adequate results with lower doses. The combination provides effective HbA1c reduction, weight neutrality, and a convenient once-daily oral therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Coport L Tablet 25 mg + 5 mg is indicated for:

• Adults with type 2 diabetes mellitus inadequately controlled by diet, exercise, or lower-dose therapy
• Patients requiring combination therapy for better glycemic management
• Adjunct therapy with other antidiabetic medications as prescribed
• Reducing the risk of cardiovascular complications associated with type 2 diabetes

Mechanism of Action

• Empagliflozin (25 mg): Inhibits SGLT2 in the proximal renal tubules, reducing glucose reabsorption and increasing urinary glucose excretion, leading to lower blood sugar levels.
• Linagliptin (5 mg): Inhibits DPP-4 enzyme, increasing active incretin hormones, stimulating insulin release, and suppressing glucagon secretion in a glucose-dependent manner.

The combination provides complementary mechanisms for enhanced blood glucose control, weight neutrality, and minimal risk of hypoglycemia.

Dosage and Administration

• The usual adult dose is one tablet once daily, taken with or without food
• Swallow the tablet whole with water
• Maintain a healthy diet and regular physical activity
• Adhere to the prescribed course for optimal results

Benefits

• Effective dual-action therapy for better glycemic control
• Convenient once-daily oral administration
• Helps reduce HbA1c levels significantly
• Weight-neutral with low risk of hypoglycemia
• Suitable for patients requiring higher-intensity combination therapy

Side Effects

Common side effects may include:

• Increased urination
• Nasopharyngitis
• Mild gastrointestinal discomfort
• Upper respiratory tract infection

Rare but serious side effects:

• Dehydration or electrolyte imbalance
• Urinary tract and genital infections
• Hypoglycemia, especially when combined with insulin or sulfonylureas
• Diabetic ketoacidosis or kidney problems

Seek immediate medical attention if severe side effects occur.

Precautions

• Use with caution in patients with renal or liver impairment
• Maintain adequate hydration to prevent dehydration
• Monitor blood glucose levels regularly
• Inform your doctor of all medications being taken, especially other antidiabetic drugs
• Not suitable for type 1 diabetes or diabetic ketoacidosis

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Use in Special Populations

• Pregnancy: Use only if clearly necessary and under medical supervision
• Lactation: Consult a healthcare provider before use
• Elderly: May be more susceptible to dehydration and urinary infections; careful monitoring is advised

Storage

• Store below 30°C
• Keep in a dry place, protected from light
• Keep out of reach of children.